David P. Nunes, MD, FRCPI
Associate Professor
Boston University School of Medicine
Dept of Medicine

MBBCh, Trinity College Dublin

Expertise includes: Clinical liver disease - interest in viral hepatitis; Evaluation and management of liver lesions.

Boston University
Evans Center for Interdisciplinary Biomedical Research

A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon alpha-2a (Pegasys)
11/01/2011 - 12/31/2014 (PI)
Gilead Sciences, Inc.

A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon alpha-2a (Pegasys)
11/01/2011 - 12/31/2014 (PI)
Gilead Sciences, Inc.

A Study to Describe the Safety and Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics with Chronic Hepatitis B Virus (HBV) Infection who are Nucleoside-Naive
10/17/2006 - 10/16/2008 (PI)
Bristol-Myers Squibb

A Randomized, Placebo Controlled, Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of NOV-205 in Chronic Viral Hepatitis C Subjects (Genotype 1) who have failed Treatment with Pegylated Interferon plus Ribavirin
01/23/2007 - 01/22/2008 (PI)
Novelos Therapeutics, Inc.

Phase II Study Of Long Term Peg Intron Fpr Patients Who Have Failed to Respond to Rebetron/Interferon with Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C.
05/11/2001 - 05/31/2005 (PI)
Schering Corporation

Evaluating the Erythropoietic Response to Anemia in HCV
01/01/2002 - 12/31/2003 (PI)
Ortho Biotech Inc

Comparison of PEG Interferon Alfa 2b Plus Ribavirin Given as a Fixed Dose or on a Weight Optimized Basis for Treatment of Chronic Hepatitis C in Previously Untreated Adult Subjects
12/01/2001 - 11/30/2003 (PI)
Integrated Therapeutics Group

A Prospective, Randomized, Multicenter, Open Label Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin Treatment vs. a Twelve Treatment Delay in Patients with Chronic Hepatitis C
02/06/2001 - 12/31/2002 (PI)
Roche Laboratories Inc

A Randomized, Partially Blinded, Multicenter, Phase II Study Investigating the Efficacy and Safety of Pegasys and Pegasys with Ribavirin in Treatment Naive Patients with Chronic Hepatitis C Coinfected with Human Immunodeficiency Virus
01/18/2001 - 01/31/2002 (PI)
Roche Laboratories Inc


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gilad A, Fricker ZP, Hsieh A, Thomas DD, Zahorian T, Nunes DP. Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy. J Clin Gastroenterol. 2019 09; 53(8):616-620.View Related Profiles. PMID: 30614943
  2. Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 07; 64(7):2031-2038.View Related Profiles. PMID: 30945037
  3. Tran AN, Sachdev R, Fricker ZP, Leber M, Zahorian T, Shah B, Nunes DP, Long MT. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital. Dig Dis Sci. 2018 12; 63(12):3241-3249.View Related Profiles. PMID: 30078116
  4. Reddy YNV, Nunes D, Chitalia V, Gordon CE, Francis JM. Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents. Hemodial Int. 2018 04; 22 Suppl 1:S53-S60.View Related Profiles. PMID: 29694721
  5. Baranoski AS, Cotton D, Heeren T, Nunes D, Kubiak RW, Horsburgh CR. Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men. Open Forum Infect Dis. 2016 Jan; 3(1):ofv214.View Related Profiles. PMID: 26955643; DOI: 10.1093/ofid/ofv214;
  6. Anderson JP, Horsburgh CR, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR. CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis. 2015 Jan; 2(1):ofv019.View Related Profiles. PMID: 26034769; DOI: 10.1093/ofid/ofv019;
  7. Fuster D, Cheng DM, Quinn EK, Nunes D, Saitz R, Samet JH, Tsui JI. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Addiction. 2014 Jan; 109(1):62-70.View Related Profiles. PMID: 24112091; PMCID: PMC3947001; DOI: 10.1111/add.12367;
  8. Okafor PN, Nunes DP, Farraye FA. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? Inflamm Bowel Dis. 2013 Jul; 19(8):1764-71.View Related Profiles. PMID: 23615530; DOI: 10.1097/MIB.0b013e318281f562;
  9. Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses. 2013 Aug; 29(8):1110-6.View Related Profiles. PMID: 23601055; PMCID: PMC3715787; DOI: 10.1089/AID.2012.0348;
  10. Fuster D, Tsui JI, Cheng DM, Quinn EK, Bridden C, Nunes D, Libman H, Saitz R, Samet JH. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. Alcohol Clin Exp Res. 2013 Sep; 37(9):1527-35.View Related Profiles. PMID: 23647488; PMCID: PMC3758457; DOI: 10.1111/acer.12129;
Showing 10 of 56 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 56 publications over 21 distinct years, with a maximum of 5 publications in 2007


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Hepatitis B
Hepatitis C
Liver fibrosis
Contact for Mentoring:

85 E. Concord St
Boston MA 02118
Google Map

Nunes's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department